Medical and scientific publishing firm Elsevier has bought InferMed, the UK-based company that produces the Arezzo clinical decision support system widely used by GPs in New Zealand.
Arezzo technology supports clinicians in choosing the most appropriate treatment path for each patient by matching the appropriate evidence-based guidelines with patient information and evaluating best-practice options in the light of current patient and disease information.
InferMed clinical decision support systems are installed in several regional and national health systems that provide patient-facing self-care advice, such as the NHS's symptom checker, as well as supporting nurse triage telephone services including those provided by Medibank Health Solutions.
